DCTH - Delcath Systems, Inc.

Delcath Systems, Inc. , an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

As of May 15, 2026: spot at $11.11, ATM IV 65.8%, net GEX $24.8K.

Sector
Healthcare
Industry
Medical - Devices
Market Cap
$400.8M
P/E Ratio
745.47
Beta
0.54
52-Week Range
8.12-18.23
CEO
Gerard J. Michel
Employees
96
IPO Date
May 3, 2018
Exchange
NASDAQ

What DCTH Looks Like to Options Traders Today

IV rank of 10.3% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($24.8K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.081) prices calls richer than puts, often reflecting upside speculation or squeeze risk.

What This Page Covers

The DCTH overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.

Frequently asked DCTH overview questions

What is DCTH?
DCTH is the ticker symbol for Delcath Systems, Inc., a listed security. Delcath Systems, Inc. , an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Listed on NASDAQ. DCTH is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
What does the DCTH options snapshot look like today?
As of May 15, 2026, the DCTH options snapshot shows spot at $11.11, ATM IV 65.8%, IV rank 10.3%, net GEX $24.8K, expected move 18.86%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
What are DCTH's key statistics?
Delcath Systems, Inc. (DCTH) carries a market capitalization of $400.8M, trailing P/E ratio of 745.47, beta of 0.54 relative to the broader market, 52-week range of 8.12-18.23. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
What sector or industry does DCTH belong to?
Delcath Systems, Inc. operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare DCTH's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
How current is the DCTH data on this page?
The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).